MedTrace Logo

Posterior Tibial Transcutaneous Neurostimulation in Idiopathic Overactive Bladder

NCT06484023 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2024-07-03

No results posted yet for this study

Summary

Overactive bladder is a clinical diagnosis affecting up to 17% of women. The existing medical treatment, anticholinergics, has many side effects and is sometimes ineffective. Neurostimulation of the posterior tibial nerve is a validated 3rd-line therapy, after failure of perineal re-education and medication. Studies on TENS have shown a real impact on patients quality of life and encourage its use in routine clinical practice. TENSI+ medical device is a treatment for overactive bladder. It is non-invasive, placed over the posterior tibial nerve pathway and sends electrical stimulation via electrodes located on the skin. Discreet and without side effects for users, this treatment is indicated as 3rd-line treatment for people suffering from idiopathic overactive bladder with no contraindications. The aim of this study is to assess the quality of life of patients using this device, both before use and after at least 3 months of use.

Conditions

Interventions

OTHER

Survey

quality of life questionnaire

Sponsors & Collaborators

  • Hopital Nord Franche-Comte

    lead OTHER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-29
Primary Completion
2024-04-26
Completion
2024-06-17

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06484023 on ClinicalTrials.gov